Insider · CIK 0001256230

BROSHY ERAN

Reports to the SEC for 5 companies · RADNOR, PA

sec.gov

Transactions

Companies

Filings

CIK

0001256230

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chairman	MExercise/Conversion	−15.8K sh	—	—	0
2026-05-14	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director, Chairman	AAward	+33.2K sh	—	—	33,222
2026-05-14	CERTCertara, Inc.M Exercise/Conversion	Director, Chairman	MExercise/Conversion	+15.8K sh	—	—	50,708
2025-11-26	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+14K sh	$10.15	+$142K	81,749
2025-11-26	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−14K sh	$20.00	−$280K	60,204
2025-11-26	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−15.5K sh	$20.00	−$310K	44,703
2025-11-11	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+14K sh	$10.15	+$142K	107,878
2025-11-11	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−14K sh	$18.50	−$259K	60,204
2025-11-11	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−15.5K sh	$17.00	−$264K	60,204
2025-11-11	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−29.5K sh	$18.50	−$546K	61,704
2025-11-11	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−15.5K sh	$17.00	−$264K	46,204
2025-11-11	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−15.5K sh	$18.50	−$287K	75,704
2025-11-11	TBPHTheravance Biopharma, Inc.S Sale	Director	SSale	−14K sh	$18.50	−$259K	46,204
2025-11-11	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+14K sh	$10.15	+$142K	107,878
2025-05-21	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chairman	MExercise/Conversion	−11.9K sh	—	—	0
2025-05-21	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director, Chairman	AAward	+15.8K sh	—	—	15,757
2025-05-21	CERTCertara, Inc.M Exercise/Conversion	Director, Chairman	MExercise/Conversion	+11.9K sh	—	—	34,951
2025-05-19	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.6K sh	—	—	91,204
2025-05-19	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,258
2024-05-21	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director, Chairman	AAward	+11.9K sh	—	—	11,928
2024-05-21	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chairman	MExercise/Conversion	−8,663 sh	—	—	0
2024-05-21	CERTCertara, Inc.M Exercise/Conversion	Director, Chairman	MExercise/Conversion	+8,663 sh	—	—	23,023
2024-05-08	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+23.6K sh	—	—	23,576
2024-05-08	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.5K sh	—	—	80,555
2023-08-22	CERTCertara, Inc.P Purchase	Director, Chairman	PPurchase	+4,807 sh	$15.80	+$76K	14,360
2023-08-21	CERTCertara, Inc.P Purchase	Director, Chairman	PPurchase	+193 sh	$16.10	+$3,107.3	9,553
2023-05-23	CERTCertara, Inc.M Exercise/Conversion	Director, Chairman	MExercise/Conversion	+9,360 sh	—	—	9,360
2023-05-23	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director, Chairman	AAward	+8,663 sh	—	—	8,663
2023-05-23	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chairman	MExercise/Conversion	−9,360 sh	—	—	0
2023-05-02	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,132 sh	—	—	70,018
2023-05-02	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,044
2022-07-13	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director, Chairman	AAward	+9,360 sh	—	—	9,360
2022-04-26	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2022-04-26	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,852 sh	—	—	60,886
2021-04-27	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2021-04-27	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,828 sh	—	—	51,034
2020-04-28	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,635 sh	—	—	41,206
2020-04-28	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-04-30	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-04-30	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+8,385 sh	—	—	34,571
2018-05-24	MAGELLAN HEALTH INCA Award	Director	AAward	+1,685 sh	—	—	9,645
2018-05-01	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2018-05-01	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+8,186 sh	—	—	26,186
2017-05-24	MAGELLAN HEALTH INCA Award	Director	AAward	+2,137 sh	—	—	10,097
2017-05-17	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,000 sh	—	—	18,000
2017-02-23	MAGELLAN HEALTH INCS Sale	Director	SSale	−4,867 sh	$80.00	−$389K	7,960
2016-12-08	MAGELLAN HEALTH INCS Sale	Director	SSale	−2,433 sh	$75.00	−$182K	12,827
2016-05-18	MAGELLAN HEALTH INCA Award	Director	AAward	+2,295 sh	—	—	15,260
2016-05-03	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,000 sh	—	—	12,000
2015-05-20	MAGELLAN HEALTH INCA Award	Director	AAward	+2,235 sh	—	—	12,965

Recent filings

Accepted (ET)
May 154
BROSHY ERAN0001256230-26-000002
SEC(opens sec.gov)
Dec 14
BROSHY ERAN0001256230-25-000009
SEC(opens sec.gov)
Nov 144/A
BROSHY ERAN0001256230-25-000007
SEC(opens sec.gov)
Nov 134
BROSHY ERAN0001256230-25-000006
SEC(opens sec.gov)
May 224
BROSHY ERAN0001415889-25-014182
SEC(opens sec.gov)
May 214
BROSHY ERAN0001415889-25-014000
SEC(opens sec.gov)
May 234
BROSHY ERAN0001415889-24-014248
SEC(opens sec.gov)

Companies

Address

C/O CERTARA, INC. 4 RADNOR CORPORATE CENTER, SUITE 350

RADNOR, PA, 19087